November 21, 2006. Judit Rius Sanjuan, James Love, Robert Weissman.
Protection of Pharmaceutical Test Data: A Policy Proposal. Consumer Project on Technology.
October 26, 2006. James Love.
"Use of competition rules to address abuses of intellectual property rights." In Trinidad at the CARRIBEAN REGIONAL WORKSHOP ON INTELLECTUAL PROPERTY AND ACCESS TO MEDICINES.
October 25, 2006. James Love.
The WHO IGWG process and new paradigms for supporting R&D. In Trinidad.
August 30, 2006. Ben Krohmal.
"IRS Data Show Increasing Pharma Income from Royalties." Drug Development.
July 31, 2006. Julie Patel.
"Korean A-7 Prices Compared to U.S. Prices." Drug Development.
July 17, 2006. James Love.
"PhRMA says industry wide R&D outlays on medicines were $51.3 billion in 2005." Drug Development.
July 14, 2006. James Love.
"Size of trials by status (S or P) - Some 2004 FDA and Parexel data compared." Drug Development.
July 12, 2006. James Love in the Huffington Post.
Korea FTA negotiations on medicines will harm us too.
July 10, 2006. Mike Palmedo.
"Bayh Dole Rights, Size of Clinical Trials, 2004 Approvals.." Drug Development.
July 10, 2006. James Love.
"CPTech Comments on the APC/AMC Approaches." Drug Development.
July 09, 2006. James Love.
"AMC mention in July 10 Pre Summit Statement by G8 Finance Ministers." Drug Development.
July 08, 2006. James Love.
"Simulating prize fund rewards ." Drug Development.
July 07, 2006. James Love.
"Modeling prize fund rewards." Drug Development.
July 04, 2006. James Love.
"Prize fund and size of client population." Drug Development.
May, 2006. James Love.
"Drug development incentives to improve access to essential medicines." Bulletin of the World Health Organization. 84(5).
May, 2006. James Love,
"A new initiative at the WHO, Prizes rather than prices," Le Monde diplomatique.
May 18, 2006. Judit Rius Sanjuan, James Love & Robert Weissman.
"A cost sharing model to protect investments in pharmaceutical test data." CPTech Policy Brief No. 1.
April 12, 2006. Judit Rius Sanjuan.
"US and EU Protection of Pharmaceutical Test Data." CPTech Discussion Paper No. 1.
April 3, 2006. Judit Rius Sanjuan.
"Patent-Registration Linkage." CPTech Discussion Paper No. 2.
March 27, 2006. James Love in the Huffington Post.
Globalization in a Good Way? - What the US/Korea FTA Could Be About
March 13, 2006. CPTech Blogs on the USTR Hearings on the FTA.
March 1, 2006. James Love.
"Measures to Enhance Access to Medical Technologies, and New Methods of Stimulating Medical R&D." Paper prepared for the WIPO Open Forum on the draft Substantive Patent Law Treaty (SPLT).
March, 2006.
"WHO to Debate Global R&D Framework." James Love in Real Health News, no. 4.
March, 2006. Judit Rius Sanjuan.
"Response to 2006 PhRMA "Special 301" Submission for Chile."
2006, James Love, "Four Practical Measures to Enhance Access to Medical Technologies," chapter in
Negotiating Health, Earthscan, Edited by Pedro Roffe, Geoff Tansey and David Vivas-Eugui.
2005. James Love.
"Remuneration Guidelines for Non-Voluntary Use of a Patent on Medical Technologies." Paper published by the World Health Organization. Health Economics and Drugs, TCM Series No. 18.
2005. James Love and Tim Hubbard.
"Paying for Public Goods." Essay published as a chapter of the book
Code, Edited by Rishab Aiyer Ghosh. (MIT Press.)
December 2005. James Love,
"Managing Patents on Medicines," in
Bridges, Year 9, Number 10.
October 28, 2005,. James Love, "A Better Way of Stockpiling Medicines,"
Financial Times,
with subscription, or
without.
February 24, 2005.
Sign on letter to the World Health Organizations's Commission on Intellectual
Property, Innovation and Health The letter asks the Commission to
evaluate a new treaty framework for medical R&D.
February 7, 2005.
Draft Version 4 of the proposed Medical Research and Development Treaty.
July 22, 2004. Consumer Project on Technology, Consumers Union, Consumer Federation
of America, Health Action International, Essential Action, and Consumer Action.
Joint letter to US Trade Representative Robert Zoellick.
July 1, 2004.
CPTech comments on US Department of Commerce, DHHS and USTR Study of International Drug Pricing, proposing R&D+ as alternative trade framework.
June, 2004. James Love and Tim Hubbard in Bridges.
Make Drugs Affordable: Replace TRIPs-plus by R&D-plus.
May 18, 2004. James V. Delong's.
Peddling Dope: Open Source Drug Development Tech Central Station Daily.
April 23, 2004.
Bipartisan drug import bill fixes exhaustion and
contract barriers, runs afoul of FTAs and Hague Convention.
April 14, 2004,
Policy Issues Concerning Parallel Trade of Pharmaceutical
Drugs in the United States,
March 31, 2004
Legal and Policy Issues Concerning Parallel Trade (aka Re-Importation) Of
Pharmaceutical Drugs in the United States
March 30, 2004, CPTech statement to Members of Study Group on
Enforcement of Judgments, Secretary of State Advisory
Committee on Private International Law, regarding
First Sale Doctrine (parallel trade, exhaustion of intellectual
property rights).
March 4, 2004. Op-ed by James Love and Tim Hubbard published in the Guardian.
We're Patently Going Mad: Lifesaving drugs must be developed differently -
for all our sakes.
March 3, 2004,
Comments on Maryland State Senate Bill 167.
February 2, 2004. Essay by James Love and Tim Hubbard published in the PLoS Biology.
A New Trade Framework for Global Healthcare R&D.
December 4, 2003. Paper presentend by James Love at Columbia University's
Workshop on Access to Medicines and the Financing of Innovations in Heath Care.
A New Trade Framework for Global Healthcare R&D. Also, see the
Conference Home Page.
September 22, 2003. James Love.
"Evidence Regarding Research and Development Investments in Innovative and Non-Innovative Medicines." Consumer Project on Technology.
July 7, 2003. Letter from 63 experts and stakeholdedras to
Kamil Idris, Director-General of WIPO,
requesting that WIPO host a meeting on open collaborative development
models. Available in
PDF format
and
plain text.
June 24, 2003. Tim Hubbard and James Love. Paper presented at the
Meeting on The Role of Generics and Local Industry in Attaining the Millennium
Development Goals (MDGs) in Pharmaceuticals and Vaccines held at the World Bank.
An Agenda for Research and Development.
June 14, 2003. Tim Hubbard and James Love in the New Scientist.
Medicines without barriers. New Scientist.com
May 27, 2003 James Love.
From TRIPS to RIPS: A better Trade Framework to support Innovation in
Medical Technologies. (MS Word format) Presented at the Workshop on
Economic issues related to access to HIV/AIDS care in developing countries,
Agence nationale de recherches sur le sida, Marsielle, France.
April 29, 2003. James Love. Presentation at the Meeting on global
framework for supporting health research and development (R&D) in areas of
market and public policy failure, Geneva, Switzerland.
Basis for a treaty on R&D.
December 3, 2002. James Love.
"The Benefits of a Treaty on R&D." PPT presentation given at
The Drugs for Neglected Diseases (DND) Working Group, in Rio de Janerio, Brazil.
December 10, 2001 request by
Michael Palmedo to discuss issue of the first sale doctine.
November 28, 2001. Michael Palmedo.
Costs of Human Use Clinical Trials: Surprising Evidence from the US Orphan Drug Act.
November 10, 2001. James Love.
Letter from James Love to US Trade Representative Robert Zoellick
regarding trade negotiations at Doha.
October 7, 2001.
Request that WHO seek compulsory licenses for 5 essential antiretrovial products in Sub-Saharan Africa.
September 29, 2001.
Examples of Compulsory Licensing in the United States.
October 23-24, 2000. James Love.
"Paying for health care R&D: Carrots and Sticks." Paper presented to the MSF working group on R&D. Geneva.
April 2, 2000. James Love.
"How Much does it cost to develop a new drug,"paper for Geneva meeting of the MSF Working Group on R&D.
January 1999. James Love,
"Preliminary thoughts on a program for Essential Health Research".
